TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
TCL Archive GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds April 21, 1989